Reversible cerebral vasoconstriction syndrome (RCVS) usually presents with recurrent thunderclap headaches and is characterized by multifocal and reversible vasoconstriction of cerebral arteries that can sometimes evolve to severe cerebral ischemia and stroke. We describe the case of a patient who presented with a clinically typical RCVS and developed focal neurological symptoms and signs despite oral treatment with calcium channel blockers. Within hours of neurological deterioration, she was treated with intra‐arterial milrinone, a phosphodiesterase inhibitor, which resulted in a rapid and sustained neurological improvement.
Background and Purpose-The purpose of this study was to estimate the performance measures of MR angiography (MRA) in the diagnosis of aneurysm residual flow after coil occlusion. Methods-Patients having at least 1 cerebral aneurysm treated with coil occlusion were prospectively and consecutively enrolled. Time of flight and contrast-enhanced MRA were performed the same day of the DSA follow-up. The degree of aneurysm occlusion and dimensions of the residual flow were evaluated by independent readers at MRA and digital subtraction angiogram. MRA performance measures were estimated in a cross-sectional analysis and repeated in subgroups of aneurysm sizes and locations. MRA predictive values for recurrence were also estimated using a longitudinal design. Results-We obtained 167 aneurysm evaluations for each imaging modality. Class 3 residual flow was seen on digital subtraction angiogram follow-up in 27%. The sensitivity and specificity of MRA was 88% (95% CI, 80 -94) and 79% (95% CI, 67-88), respectively. The positive predictive value for a Class 3 recurrence was 67% (95% CI, 51-80) and the negative predictive value was 93% (95% CI, 86 -97). Time-of-flight MRA underestimated the length of the residual flow (Pϭ0.039), whereas contrast-enhanced MRA overestimated its width (PϽ0.0001). MRA sensitivity for a Class 3 residual flow was lower for aneurysms Ͻ6 mm (Pϭ0.01). Conclusions-MRA has sufficient accuracy for screening of aneurysm residual flow after coil occlusion. Due to its lower negative predictive value, recurrent aneurysms should be confirmed with digital subtraction angiogram before planning a retreatment. Routine use of MRA to follow small aneurysms should wait better estimation of its performance in this particular subgroup. (Stroke. 2012;43:740-746.)
492In Canada, neurologic determination of death (NDD) or brain death (BD) diagnosis is based on five clinicals criteria: established etiology capable of causing NDD, deep unresponsive coma, absent brainstem reflexes, absent breathing reflex and absent confounding factors. 1 However, ancillary tests are sometimes necessary when the clinical exam cannot be completely performed or when confounding factors are present. Recently, a Canadian workforce of experts in brain death and organ donation published guidelines on the use of ancillary tests for NDD. 2 Among their recommendations, they stated that "Absence of brain blood flow is the imaging and physiological correlate of brain arrest and brain death. From an imaging point of view, brain blood flow refers to intra-arterial filling and the ABSTRACT: Background: In Canada, ancillary tests, such as selective four vessels angiography (S4VA), are sometimes necessary for brain death (BD) diagnosis when the clinical exam cannot be completed or confounding factors are present. Recent Canadian guidelines assert that brain death is supported by the absence of arterial blood flow at the surface of the brain and that venous return should not be considered. However, neuropathologic and angiographic studies have suggested that arteries might still be patent in BD patients. Current clinical practices in BD diagnosis following S4VA need to be better understood. Methods: We conducted a retrospective study of all S4VA performed for the determination of BD in a level 1 NeuroTrauma centre from 2003 to 2007. The objective of the study was to describe the prevalence of intracranial arterial, capillary (parenchymogram) and venous opacification in our study population. All tests were reviewed independently by two neuroradiologists. Disagreements were resolved by consensus. Results: Thirty two patients were declared BD following S4VA during the study period. Nine of these patients (28%) presented some proximal opacification of intracranial arteries (95% CI 15-45%). As opposed, none had a cerebral capillary and deep venous drainage opacification (95% CI 0-10%). Conclusion: The absence of cerebral deep venous drainage or parenchymogram might represent a better objective marker of cerebral circulatory arrest for brain death diagnosis when the use of S4VA is required. These findings open the path for further research in enhancing our interpretation of angiographic studies for brain death diagnosis.RÉSUMÉ: Étude rétrospective de l'angiographie sélective des 4 vaisseaux pour le diagnostic de la mort cérébrale. Contexte : Au Canada, des tests complémentaires tels l'angiographie sélective des 4 vaisseaux (AS4V) sont parfois nécessaires pour poser le diagnostic de mort cérébrale (MC) quand l'examen clinique est impossible ou lorsque des facteurs confondants sont présents. Selon des lignes directrices canadiennes récentes, la mort cérébrale est confirmée par l'absence de flux sanguin artériel à la surface du cerveau sans tenir compte du retour veineux. Cependant, des études neuropathologiques et ang...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.